The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells
Article in Toxicology and Applied Pharmacology (March 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development
Article in Life Sciences (November 2023)
Optimized lipopolymers with curcumin to enhance AZD5582 and GDC0152 activity and downregulate inhibitors of apoptosis proteins in glioblastoma multiforme
Article in Biomaterials Advances (September 2023)